Browse > Article
http://dx.doi.org/10.3857/roj.2012.30.1.1

Basics of particle therapy II: relative biological effectiveness  

Choi, Jin-Hyun (Department of Radiation Oncology, Kyung Hee University School of Medicine)
Kang, Jin-Oh (Department of Radiation Oncology, Kyung Hee University School of Medicine)
Publication Information
Radiation Oncology Journal / v.30, no.1, 2012 , pp. 1-13 More about this Journal
Abstract
In the previous review, the physical aspect of heavy particles, with a focus on the carbon beam was introduced. Particle beam therapy has many potential advantages for cancer treatment without increasing severe side effects in normal tissue, these kinds of radiation have different biologic characteristics and have advantages over using conventional photon beam radiation during treatment. The relative biological effectiveness (RBE) is used for many biological, clinical endpoints among different radiation types and is the only convenient way to transfer the clinical experience in radiotherapy with photons to another type of radiation therapy. However, the RBE varies dependent on the energy of the beam, the fractionation, cell types, oxygenation status, and the biological endpoint studied. Thus this review describes the concerns about RBE related to particle beam to increase interests of the Korean radiation oncologists' society.
Keywords
Carbon; Proton; Particle beam therapy; Relative biological effectiveness;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ito A, Nakano H, Kusano Y, et al. Contribution of indirect action to radiation-induced mammalian cell inactivation: dependence on photon energy and heavy-ion LET. Radiat Res 2006;165:703-12.   DOI
2 Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:201-10.   DOI
3 Skarsgard LD. Radiobiology with heavy charged particles: a historical review. Phys Med 1998;14 Suppl 1:1-19.
4 Ballarini F. From DNA radiation damage to cell death: theoretical approaches. J Nucleic Acids 2010;2010:350608.
5 Lea DE. Actions of radiations on living cells. 2nd ed. London: Cambridge University Press; 1955.
6 Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
7 Chadwick KH, Leenhouts HP. A molecular theory of cell survival. Phys Med Biol 1973;18:78-87.   DOI
8 Dale RG, Jones B. The assessment of RBE effects using the concept of biologically effective dose. Int J Radiat Oncol Biol Phys 1999;43:639-45.   DOI
9 ICRP. 1990 recommendations of the International Commission on Radiological Protection. Ann ICRP 1991;21(1-3):1-201.   DOI
10 ICRP. The 2007 recommendations of the International Commission on Radiological Protection: ICRP publication 103. Ann ICRP 2007;37(2-4):1-332
11 Particle Therapy Co-operative Group (PTCOG). Patient statistics per end of 2010 [Internet]. PTCOG; 2011 [cited 2011 Mar 20]. Available from: http://ptcog.web.psi.ch/patient_statistics.html.
12 Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-21.   DOI
13 Fokas E, Kraft G, An H, Engenhart-Cabillic R. Ion beam radiobiology and cancer: time to update ourselves. Biochim Biophys Acta 2009;1796:216-29.
14 Schardt D, Elsasser T, Schulz-Ertner D. Heavy-ion tumor therapy: physical and radiobiological benefits. Rev Mod Phys 2010;82:383-425.   DOI
15 International Commission on Radiation Units and Measurements (ICRU). Prescribing, recording, and reporting protonbeam therapy. J ICRU 2007;7:1-210.
16 Wambersie A. RBE, reference RBE and clinical RBE: applications of these concepts in hadron therapy. Strahlenther Onkol 1999;175 Suppl 2:39-43.
17 Gueulette J, Slabbert JP, Bohm L, et al. Proton RBE for early intestinal tolerance in mice after fractionated irradiation. Radiother Oncol 2001;61:177-84.   DOI
18 Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006;65:1-7.   DOI
19 Paganetti H, Gerweck LE, Goitein M. The general relation between tissue response to x-radiation (alpha/beta-values) and the relative biological effectiveness (RBE) of protons: prediction by the Katz track-structure model. Int J Radiat Biol 2000;76:985-98.   DOI
20 Lee KB, Lee JS, Park JW, Huh TL, Lee YM. Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases. Exp Mol Med 2008;40:118-29.   DOI
21 Weyrather WK, Ritter S, Scholz M, Kraft G. RBE for carbon track-segment irradiation in cell lines of differing repair capacity. Int J Radiat Biol 1999;75:1357-64.   DOI
22 Takahashi A, Yano T, Matsumoto H, et al. Effects of accelerated carbon-ions on growth inhibition of transplantable human esophageal cancer in nude mice. Cancer Lett 1998;122:181-6.   DOI
23 Kitabayashi H, Shimada H, Yamada S, et al. Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation. Oncol Rep 2006;15:913-8.
24 Koike S, Ando K, Oohira C, et al. Relative biological effectiveness of 290 MeV/u carbon ions for the growth delay of a radioresistant murine fibrosarcoma. J Radiat Res 2002;43:247-55.   DOI
25 Peschke P, Karger CP, Scholz M, Debus J, Huber PE. Relative biological effectiveness of carbon ions for local tumor control of a radioresistant prostate carcinoma in the rat. Int J Radiat Oncol Biol Phys 2011;79:239-46.   DOI
26 Kramer M, Weyrather WK, Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat 2003;2:427-36.   DOI
27 Suit H, DeLaney T, Goldberg S, et al. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol 2010;95:3-22.   DOI
28 Furusawa Y, Fukutsu K, Aoki M, et al. Inactivation of aero bic and hypoxic cells from three different cell lines by accele rated (3)He-, (12)C- and (20)Ne-ion beams. Radiat Res 2000;154:485-96.   DOI
29 Kraft G. Tumor therapy with heavy charged particles. Prog Part Nucl Phys 2000;45:S473-544.   DOI
30 Suzuki M, Kase Y, Yamaguchi H, Kanai T, Ando K. Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams. Int J Radiat Oncol Biol Phys 2000;48:241-50.
31 Belli M, Bettega D, Calzolari P, et al. Effectiveness of monoenergetic and spread-out bragg peak carbon-ions for inactivation of various normal and tumour human cell lines. J Radiat Res 2008;49:597-607.   DOI
32 Schulz-Ertner D, Jakel O, Schlegel W. Radiation therapy with charged particles. Semin Radiat Oncol 2006;16:249-59.   DOI
33 Blakely EA, Chang PY. Late effects from hadron therapy. Radiother Oncol 2004;73 Suppl 2:S134-40.
34 Ando K, Kase Y. Biological characteristics of carbon-ion therapy. Int J Radiat Biol 2009;85:715-28.   DOI
35 George K, Durante M, Willingham V, et al. Biological effectiveness of accelerated particles for the induction of chromosome damage measured in metaphase and interphase human lymphocytes. Radiat Res 2003;160:425-35.   DOI
36 Han ZB, Suzuki H, Suzuki F, et al. Relative biological effectiveness of accelerated heavy ions for induction of morphological transformation in Syrian hamster embryo cells. J Radiat Res 1998;39:193-201.   DOI
37 Karger CP, Peschke P, Sanchez-Brandelik R, Scholz M, Debus J. Radiation tolerance of the rat spinal cord after 6 and 18 fractions of photons and carbon ions: experimental results and clinical implications. Int J Radiat Oncol Biol Phys 2006;66:1488-97.   DOI
38 Czub J, Banas D, Blaszczyk A, et al. Biological effectiveness of (12)C and (20)Ne ions with very high LET. Int J Radiat Biol 2008;84:821-9.   DOI
39 Dale RG, Jones B, Carabe-Fernandez A. Why more needs to be known about RBE effects in modern radiotherapy. Appl Radiat Isot 2009;67:387-92.   DOI
40 Dasu A, Toma-Dasu I. What is the clinically relevant relative biologic effectiveness? a warning for fractionated treatments with high linear energy transfer radiation. Int J Radiat Oncol Biol Phys 2008;70:867-74.   DOI
41 Suzuki M, Kase Y, Kanai T, Ando K. Correlation between cell killing and residual chromatin breaks measured by PCC in six human cell lines irradiated with different radiation types. Int J Radiat Biol 2000;76:1189-96.   DOI
42 Elsasser T, Kramer M, Scholz M. Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. Int J Radiat Oncol Biol Phys 2008;71:866-72.   DOI
43 Uzawa A, Ando K, Koike S, et al. Comparison of biological effectiveness of carbon-ion beams in Japan and Germany. Int J Radiat Oncol Biol Phys 2009;73:1545-51.   DOI
44 Gueulette J, Gregoire V, Octave-Prignot M, Wambersie A. Measurements of radiobiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvainla-Neuve, Belgium. Radiat Res 1996;145:70-4.   DOI
45 Gerweck LE, Kozin SV. Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol 1999;50:135-42.   DOI
46 Kim SS, Choo DW, Shin D, et al. In vivo radiobiological characterization of proton beam at the National Cancer Center in Korea: effect of the Chk2 mutation. Int J Radiat Oncol Biol Phys 2011;79:559-62.   DOI
47 Blattmann H. Beam delivery systems for charged particles. Radiat Environ Biophys 1992;31:219-31.   DOI
48 Scholz M, Kellerer AM, Kraft-Weyrather W, Kraft G. Computation of cell survival in heavy ion beams for therapy: the model and its approximation. Radiat Environ Biophys 1997;36:59-66.   DOI
49 Baek HJ, Kim TH, Shin D, et al. Radiobiological characterization of proton beam at the National Cancer Center in Korea. J Radiat Res 2008;49:509-15.   DOI